Free Trial

Electromed (ELMD) Competitors

Electromed logo
$18.82 +0.18 (+0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$18.82 0.00 (0.00%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. EMBC, CBLL, SMLR, KIDS, AXGN, AVNS, ZIMV, BVS, BFLY, and DCTH

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Embecta (EMBC), CeriBell (CBLL), Semler Scientific (SMLR), OrthoPediatrics (KIDS), AxoGen (AXGN), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Bioventus (BVS), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Electromed vs. Its Competitors

Embecta (NASDAQ:EMBC) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

Embecta has higher revenue and earnings than Electromed. Embecta is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Embecta$1.12B0.61$78.30M$0.9013.03
Electromed$61.44M2.57$5.15M$0.7923.82

Embecta has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Embecta currently has a consensus target price of $19.00, suggesting a potential upside of 61.98%. Electromed has a consensus target price of $33.50, suggesting a potential upside of 78.00%. Given Electromed's stronger consensus rating and higher possible upside, analysts plainly believe Electromed is more favorable than Embecta.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Embecta
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00

Electromed has a net margin of 11.34% compared to Embecta's net margin of 4.89%. Electromed's return on equity of 15.71% beat Embecta's return on equity.

Company Net Margins Return on Equity Return on Assets
Embecta4.89% -19.67% 12.27%
Electromed 11.34%15.71%13.37%

In the previous week, Electromed had 4 more articles in the media than Embecta. MarketBeat recorded 8 mentions for Electromed and 4 mentions for Embecta. Electromed's average media sentiment score of 0.79 beat Embecta's score of 0.72 indicating that Electromed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Embecta
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Electromed
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.8% of Embecta shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 0.4% of Embecta shares are held by company insiders. Comparatively, 14.0% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Electromed beats Embecta on 11 of the 17 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$157.83M$32.53M$5.74B$21.13B
Dividend YieldN/AN/A4.60%3.58%
P/E Ratio25.092.8728.1127.87
Price / Sales2.57195.12461.3759.63
Price / Cash41.3641.3636.5523.02
Price / Book3.692.038.654.69
Net Income$5.15M-$2.66M$3.25B$995.51M
7 Day Performance3.24%0.84%4.20%1.64%
1 Month Performance-14.10%26.50%10.82%5.92%
1 Year Performance26.90%107.35%34.70%11.50%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
1.2829 of 5 stars
$18.82
+1.0%
$33.50
+78.0%
+25.0%$157.83M$61.44M25.09160News Coverage
Analyst Forecast
Analyst Revision
EMBC
Embecta
4.6914 of 5 stars
$10.29
+5.2%
$19.00
+84.6%
-30.4%$601.35M$1.12B11.432,100
CBLL
CeriBell
2.3197 of 5 stars
$15.21
-2.4%
$32.14
+111.3%
N/A$549.74M$71.54M0.00N/A
SMLR
Semler Scientific
2.593 of 5 stars
$39.67
-3.8%
$89.00
+124.4%
+18.1%$547.05M$56.29M-15.20120Gap Down
KIDS
OrthoPediatrics
4.192 of 5 stars
$21.88
-0.6%
$35.83
+63.8%
-32.8%$531.47M$204.73M-12.50200
AXGN
AxoGen
2.2106 of 5 stars
$11.61
+2.9%
$24.50
+111.0%
+42.5%$528.72M$187.34M-77.39450
AVNS
AVANOS MEDICAL
2.9339 of 5 stars
$11.40
+1.6%
N/A-47.3%$527.14M$687.80M-1.362,227News Coverage
ZIMV
ZimVie
0.5329 of 5 stars
$18.76
+122.3%
$16.33
-12.9%
-13.0%$522.47M$449.75M-26.421,770News Coverage
Analyst Upgrade
High Trading Volume
BVS
Bioventus
N/A$6.30
+0.6%
N/AN/A$517.51M$567.70M-13.121,200
BFLY
Butterfly Network
2.4816 of 5 stars
$1.89
+0.8%
$3.50
+85.7%
+93.1%$466.14M$82.06M-6.50460News Coverage
Upcoming Earnings
DCTH
Delcath Systems
2.7728 of 5 stars
$11.32
+0.6%
$24.00
+112.0%
+29.0%$394.28M$37.21M-22.6460News Coverage

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners